openPR Logo
Press release

How COVID-19 Impacting AI for Drug Discovery Market? Top Key Players: Atomwise, Inc., Insilico Medicine, Numerate

04-22-2021 08:09 AM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
AI for Drug Discovery Market

AI for Drug Discovery Market

A new market study report by The Insight Partners on the AI for Drug Discovery Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

Click to get AI for Drug Discovery Market Research Sample PDF Copy Instantly @: https://www.theinsightpartners.com/sample/TIPRE00004177/?source=openpr-10271

What is AI for Drug Discovery?

Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity.

The AI for drug discovery market is expected to grow during the forecast period due to the increasing number of cross-industry partnerships & collaborations, a significant growth in venture capital investments, rise in importance of drug discovery and increase in funding of the R&D activities for the use of AI technology in the field of drug discovery. However, limited awareness, unwillingness among medical practitioners to adopt AI-based technologies, unclear regulatory guidelines for medical software and lack of interoperability among AI solutions offered by different vendors are likely to hamper the growth of the market in the forecast period.

The Emerging Players in the AI for Drug Discovery Market includes

Atomwise, Inc.
Insilico Medicine
BIOAGE
Numerate
NuMedii, Inc.
Envisagenics
Cloud Pharmaceuticals, Inc.
BenevolentAI
twoXAR, Incorporated
Exscientia

An Overview of the Impact of COVID-19 on this Market:

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the AI for Drug Discovery Market which would mention How the Covid-19 is Affecting the AI for Drug Discovery Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for AI for Drug Discovery Players to fight Covid-19 Impact.

The research provides answers to the following key questions:

What is the estimated growth rate of the market for the forecast period 2020–2027? What will be the market size during the estimated period?
What are the key driving forces responsible for shaping the fate of the AI for Drug Discovery market during the forecast period?
Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the AI for Drug Discovery market?
What are the prominent market trends influencing the development of the AI for Drug Discovery market across different regions?
What are the major threats and challenges likely to act as a barrier in the growth of the AI for Drug Discovery market?
What are the major opportunities the market leaders can rely on to gain success and profitability?

The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the AI for Drug Discovery market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal with regard to different segments. The report predicts the influence of different industry aspects on the AI for Drug Discovery market segments and regions.

AI for Drug Discovery Market: Regional analysis includes:

Asia-Pacific Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
North America (The United States, Mexico, and Canada.)
South America (Brazil etc.)
The Middle East and Africa (GCC Countries and Egypt.)

This report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the AI for Drug Discovery market.

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure @ https://www.theinsightpartners.com/buy/TIPRE00004177/?source=openpr-10271

Contact Us:

The Insight Partners,

Phone: +1-646-491-9876

Email: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release How COVID-19 Impacting AI for Drug Discovery Market? Top Key Players: Atomwise, Inc., Insilico Medicine, Numerate here

News-ID: 2273642 • Views:

More Releases from The Insight Partners

Farmed Salmon Market Size, Opportunities, Sales Revenue, Emerging Technologies, Competitive Landscape, Key Players Analysis and Trends by Forecast 2031
Farmed Salmon Market Size, Opportunities, Sales Revenue, Emerging Technologies, …
The Farmed Salmon Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the Farmed Salmon market growth. To get sample Copy of the
Antibody Purification Services Market - Competitive Landscape, Size, Segments, Emerging Technologies, and Growth by Forecast to 2031
Antibody Purification Services Market - Competitive Landscape, Size, Segments, E …
The Antibody Purification Services Market report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The Antibody Purification Services Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00023190?utm_source=OpenPR&utm_medium=10866 Key Player: Thermo Fisher Detai Bio-Tech Co Cusabio Genscript KMD Bioscience SouthernBiotech Pacific Immunology COVALAB Envigo The report covers key developments in the Antibody Purification Services Market as organic and inorganic growth strategies.
Rising Demand in FMCG Drives Artwork Management Software Market Growth at 9.4% CAGR by 2030
Rising Demand in FMCG Drives Artwork Management Software Market Growth at 9.4% C …
According to the new research report on "Artwork Management Software Market Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis," published by The Insight Partners, the market is expected to reach US$ 1,128.58 million by 2030 and register a CAGR of 9.4% from 2022 to 2030. Get a PDF Sample Brochure at - https://www.theinsightpartners.com/sample/TIPRE00022060/?utm_source=OpenPR&utm_medium=10196 The Europe artwork management software market is segmented into
Fire Protection Materials Market Trend Analysis, Top Manufactures and Forecast to 2031
Fire Protection Materials Market Trend Analysis, Top Manufactures and Forecast t …
The Insight Partners recently announced the release of the market research titled Fire Protection Materials Market Outlook to 2031 | Share, Size, and Growth. The report is a stop solution for companies operating in the Fire Protection Materials market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug